1,305 results on '"Reynolds, John V."'
Search Results
2. Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells
3. Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy
4. FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy
5. European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)
6. Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
7. ‘SurgTalk’: The Educational Outcomes Associated With Development of a Surgical Podcast for Undergraduate Medical Students
8. Computed tomography (CT) derived radiomics to predict post-operative disease recurrence in gastric cancer; a systematic review and meta-analysis
9. Incidence and Impact of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Adenocarcinoma of the Esophagus Treated with Curative Intent
10. Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
11. External validation of a nomogram predicting conditional survival after tri-modality treatment of esophageal cancer
12. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
13. Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study
14. Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis
15. The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy
16. Influence of postoperative complications following esophagectomy for cancer on quality of life: A European multicenter study
17. Vitamin B12 supplementation post-gastrectomy: a service closed-loop audit at St. James’s Hospital, Dublin
18. Translating evidence in a priority setting partnership: knowledge gaps between healthcare providers and oesophageal cancer patients
19. Western European Variation in the Organization of Esophageal Cancer Surgical Care
20. Successful maintenance of process and outcomes for oesophageal cancer surgery in Ireland during the first wave of the COVID-19 pandemic
21. The immune response to major gastrointestinal cancer surgery and potential implications for adjuvant immunotherapy
22. Predicting Long-term Survival and Time-to-recurrence After Esophagectomy in Patients With Esophageal Cancer: Development and Validation of a Multivariate Prediction Model
23. An International Multicenter Study Exploring Whether Surveillance After Esophageal Cancer Surgery Impacts Oncological and Quality of Life Outcomes (ENSURE)
24. Advances in the curative management of oesophageal cancer
25. C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis
26. PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma
27. Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review
28. Recurrence and Survival After Minimally Invasive and Open Esophagectomy for Esophageal Cancer: A Post Hoc Analysis of the Ensure Study.
29. Management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS trial – Authors' reply
30. Nature, severity, and impact of chronic oropharyngeal dysphagia following curative resection for esophageal cancer: a cross-sectional study
31. Targeting Radiation Resistance in Oesophageal Adenocarcinoma Through Manipulation of Energy Metabolism and Neo-Angiogenesis Using Pyrazinib Coupled with Gold Nanoparticles
32. Does Induction Therapy for T2N0 Esophageal Adenocarcinoma Patients Improve Survival?
33. Preoperative high intensity interval training for oncological resections: A systematic review and meta-analysis
34. Tissue distribution of γδ T cell subsets in oesophageal adenocarcinoma
35. The tumour immune microenvironment in oesophageal cancer
36. Embolization or disruption of thoracic duct and cisterna chyli leaks post oesophageal cancer surgery should be first line management for ECCG-defined type III chyle fistulae
37. ASO Author Reflections: Can CRP and CRP-Based Scores Predict Survival in Operable Adenocarcinomas of the Esophagus and Esophago-Gastric Junction?
38. The Complexity of Defining Postoperative Pneumonia After Esophageal Cancer Surgery: A Spectrum of Lung Injury Rather Than a Simple Infective Complication?
39. CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison
40. Challenges to quality assurance of surgical interventions in clinical oncology trials: A systematic review
41. A national survey of oncology survivors examining nutrition attitudes, problems and behaviours, and access to dietetic care throughout the cancer journey
42. Current opinions and practices for the management of acute appendicitis: an international survey
43. Modern oncological and operative outcomes in oesophageal cancer: the St. James’s hospital experience
44. Sex-related differences in oncologic outcomes, operative complications and health-related quality of life after curative-intent oesophageal cancer treatment: multicentre retrospective analysis.
45. Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma.
46. Acute Kidney Injury After Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes
47. Continuous glucose monitoring and low-glycaemic index diet in the management of postprandial hypoglycaemia after oesophagogastric cancer surgery
48. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
49. Characterizing caspase-1 involvement during esophageal disease progression
50. Identifying outcomes reported in exercise interventions in oesophagogastric cancer survivors: a systematic review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.